AxoGen, Inc. (AXGN)
NASDAQ: AXGN · IEX Real-Time Price · USD
6.01
-0.55 (-8.46%)
May 2, 2024, 1:00 PM EDT - Market open
AxoGen Revenue
In the year 2023, AxoGen had annual revenue of $159.01M with 14.74% growth. Revenue in the quarter ending December 31, 2023 was $42.92M with 18.69% year-over-year growth.
Revenue (ttm)
$159.01M
Revenue Growth
+14.74%
P/S Ratio
1.65
Revenue / Employee
$373,268
Employees
426
Market Cap
262.45M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 159.01M | 20.43M | 14.74% |
Dec 31, 2022 | 138.58M | 11.23M | 8.81% |
Dec 31, 2021 | 127.36M | 15.06M | 13.41% |
Dec 31, 2020 | 112.30M | 5.59M | 5.24% |
Dec 31, 2019 | 106.71M | 22.78M | 27.13% |
Dec 31, 2018 | 83.94M | 23.51M | 38.91% |
Dec 31, 2017 | 60.43M | 19.32M | 46.99% |
Dec 31, 2016 | 41.11M | 13.78M | 50.41% |
Dec 31, 2015 | 27.33M | 10.51M | 62.52% |
Dec 31, 2014 | 16.82M | 5.87M | 53.62% |
Dec 31, 2013 | 10.95M | 3.26M | 42.33% |
Dec 31, 2012 | 7.69M | 2.84M | 58.61% |
Dec 31, 2011 | 4.85M | 1.85M | 61.41% |
Dec 31, 2010 | 3.00M | -21.91M | -87.94% |
Dec 31, 2009 | 24.91M | 24.84M | 34,160.81% |
Dec 31, 2008 | 72.71K | -27.72K | -27.60% |
Dec 31, 2007 | 100.43K | -26.23K | -20.71% |
Dec 31, 2006 | 126.66K | -316.69K | -71.43% |
Dec 31, 2005 | 443.35K | -621.65K | -58.37% |
Dec 31, 2004 | 1.07M | - | - |
Dec 31, 2003 | 0 | - | - |
Dec 31, 2002 | 6.85M | -8.11M | -54.19% |
Dec 31, 2001 | 14.96M | 1.54M | 11.49% |
Jun 30, 2000 | 13.42M | 1.14M | 9.26% |
Jun 30, 1999 | 12.28M | -643.29K | -4.98% |
Jun 30, 1998 | 12.92M | 666.04K | 5.43% |
Jun 30, 1997 | 12.26M | -844.43K | -6.45% |
Jun 30, 1996 | 13.10M | -1.04M | -7.34% |
Jun 30, 1995 | 14.14M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GeneDx Holdings | 202.57M |
Sight Sciences | 81.06M |
Pulmonx | 68.68M |
Lyra Therapeutics | 1.56M |
Inovio Pharmaceuticals | 832.01K |
AXGN News
- 6 hours ago - Axogen, Inc Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 days ago - Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ - GlobeNewsWire
- 16 days ago - Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 - GlobeNewsWire
- 2 months ago - Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results - GlobeNewsWire
- 2 months ago - Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 - GlobeNewsWire
- 3 months ago - Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 3 months ago - Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap - GlobeNewsWire
- 4 months ago - Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 - GlobeNewsWire